CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) EBT (2013 - 2026)

CNBX Pharmaceuticals' (CNBX) quarterly EBT came in at -$162763.0 in Q2 2026, down 198.4% YoY from $165416.5 in Q2 2025, and down 303.46% on a QoQ basis from -$40342.0 in Q1 2026.

CNBX Pharmaceuticals Inc. (CNBX) EBT (2013 - 2026) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 14 years of EBT data on file, last reported at -$162763.0 in Q2 2026.

  • Quarterly EBT fell 198.4% year-over-year to -$162763.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$4.0 million (down 1690.5% YoY) and the FY2025 annual result came in at -$3.8 million, up 5.95% from the prior year.
  • EBT fell to -$162763.0 in Q2 2026, from -$40342.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of -$39959.0 in Q4 2024 to a low of -$3.7 million in Q3 2025.
  • A 5-year average of -$449751.7 and a median of -$163405.5 in 2023 frame the typical range for EBT.
  • Annual changes were most pronounced in 2023 — EBT soared 79.46% — and 2025, when it sank 6129.87%.
  • Tracing CNBX's EBT over 5 years: stood at -$351331.0 in 2022, then jumped by 47.81% to -$183351.0 in 2023, then jumped by 78.21% to -$39959.0 in 2024, then plunged by 176.03% to -$110298.0 in 2025, then slumped by 47.57% to -$162763.0 in 2026.
  • The last three EBT figures came in at -$162763.0 (Q2 2026), -$40342.0 (Q1 2026), and -$110298.0 (Q4 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
May 31, 2026 -162,763.00
Feb 28, 2026 -40,342.00
Nov 30, 2025 -110,298.00
Aug 31, 2025 -3.67 Mn
May 31, 2025 -54,546.00
Feb 28, 2025 -68,934.00
Nov 30, 2024 -39,959.00
Aug 31, 2024 -58,859.00
May 31, 2024 -152,278.00
Feb 29, 2024 -211,775.00
Nov 30, 2023 -183,351.00
Aug 31, 2023 -162,673.00
May 31, 2023 -164,048.00
Feb 28, 2023 -254,503.00
Nov 30, 2022 -351,331.00
Aug 31, 2022 -492,507.00
May 31, 2022 -681,652.00
Feb 28, 2022 -1.24 Mn
Nov 30, 2021 -1.11 Mn
Aug 31, 2021 -681,150.00